5YT-26077-09361
3 vaccinations
1 coded response
34 check-ins
1 free-text entry
1 call case
- Sex
- Female
- Age at first dose
- 0-4
- ZIP prefix
- 078 / NJ
- Registered
- 2022-06-28
- Relationship
- Child or adolescent in my care
- Guardian
- ZCW-32981-13173
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2022-06-28
Registered in v-safe
-
2022-07-19
Dose 1 — Pfizer-BioNTech
- 2022-07-19
- 2022-07-20
- 2022-07-21
- 2022-07-22
- 2022-07-23
- 2022-07-24
- 2022-07-25
- 2022-07-26
- 2022-08-02
-
2022-08-09
Dose 2 — Pfizer-BioNTech
- 2022-08-09
- 2022-08-10
- 2022-08-11
- 2022-08-12
- 2022-08-14
- 2022-08-15
- 2022-08-16
- 2022-08-23
-
2022-08-30
Survey response — day 21, dose 2, under 3MedDRA: Cough, Fatigue, Irritability, Pyrexia, Respiratory tract congestion — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: On 8/24 has fever, irritable, fatigued and started a couple days later with cough and congestion.MedDRA releases: 2024-11 · check-in free text available
-
2022-08-30
Report sent to call center — day 21, dose 2, under 3Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prTelehealth, virtual health, or email health consultation · 1 call case(s)
-
2022-08-31
Call successfulNot applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
- 2022-09-06
- 2022-09-20
-
2022-10-05
Dose 3 — Pfizer-BioNTech
-
2022-10-06
Health check-in — days 1–6 daily, dose 3, under 3Feeling: Good · Irritability/crying, Loss of appetite, DiarrheaUnder 3 check-in
- 2022-10-07
- 2022-10-08
- 2022-10-09
- 2022-10-10
- 2022-10-11
- 2022-10-12
- 2022-10-19
- 2022-10-28
- 2022-11-02
- 2022-11-09
- 2022-11-16
- 2023-01-04
- 2023-04-05
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2022-07-19 | Pfizer-BioNTech | No |
| 2 | 2022-08-09 | Pfizer-BioNTech | No |
| 3 | 2022-10-05 | Pfizer-BioNTech | No |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2022-08-30 | Successful 2022-08-31 |
Not applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill |
Free text
Release 12 (Under 3) — day 21, dose 2, under 3
Symptoms: On 8/24 has fever, irritable, fatigued and started a couple days later with cough and congestion.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Cough | · | · | ✓ |
| SD | Fatigue | · | · | ✓ |
| SD | Irritability | · | · | ✓ |
| SD | Pyrexia | · | · | ✓ |
| SD | Respiratory tract congestion | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release